TickerFacts.

Enveric Biosciences, Inc. (ENVB): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$39.91M
Year ended 2019-12-31
+3.4%
3-year compound annual growth
$48.59M2015-12-31: $20.26M2016-12-31: $36.15M2017-12-31: $48.59M2018-12-31: $43.00M2019-12-31: $39.91M$39.91M
2015-12-31 Revenue (USD) 2019-12-31
Period endedRevenueChange YoYSource filing
2019-12-31$39.91M-7.2%2020-03-25, From 2019-01-01
2018-12-31$43.00M-11.5%2020-03-25, From 2018-01-01
2017-12-31$48.59M+34.4%2019-03-26, From 2017-01-01
2016-12-31$36.15M+78.4%2018-04-02, From 2016-01-01
2015-12-31$20.26Mn/a2017-04-04, From 2015-01-01